Wilson B A, Bar-Or O, O'Byrne P M
School of Human Biology, University of Guelph, Ontario, Canada.
Eur Respir J. 1994 Dec;7(12):2174-8. doi: 10.1183/09031936.94.07122174.
Repeated exercise tests demonstrate refractoriness to the development of exercise-induced asthma (EIA). It is unclear whether it is the initial exercise per se or the resulting bronchoconstriction that causes the attenuated response to the second exercise challenge. This study was designed to determine whether the reported blocking of the refractory period by indomethacin requires a significant bronchoconstriction following the primary exercise challenge. Thirteen asthmatic teenagers (aged 12-16 yrs) were tested on four visits. Each visit included two 7 min treadmill exercise challenges at 80% maximum heart rate, separated by a 30 min rest. Conditions for the second exercise challenge (Ch2) were always thermoneutral (20-22 degrees C and 25-35% relative humidity (RH); whilst challenge one (Ch1) was completed twice in thermoneutral and twice in warm-humid breathing conditions (33-35 degrees C and 90-95% RH). A pretreatment for 3 days in a double-blind design with either placebo or indomethacin was completed. Forced expiratory volume in one second (FEV1) was measured before and repeatedly following each challenge. The % fall in FEV1 following Ch1 of the placebo thermoneutral trial was taken as reference. "Percent protection" at each visit was expressed as the decrease in EIA following Ch2, compared to reference. Warm-humid breathing reduced the EIA post Ch1 by 75%, whilst providing similar protection to thermoneutral conditions. Indomethacin had no significant effect on EIA after Ch1, but reduced "percent protection" for both warm-humid (from 67 to 16%) and thermoneutral (from 70 to 26%) conditions.(ABSTRACT TRUNCATED AT 250 WORDS)
重复进行运动测试表明对运动诱发哮喘(EIA)的发展具有不应性。尚不清楚是最初的运动本身还是由此导致的支气管收缩引起了对第二次运动挑战的反应减弱。本研究旨在确定消炎痛所报告的对不应期的阻断是否需要在初次运动挑战后出现显著的支气管收缩。对13名哮喘青少年(年龄12 - 16岁)进行了4次测试。每次测试包括两次在最大心率80%的情况下进行7分钟的跑步机运动挑战,中间休息30分钟。第二次运动挑战(Ch2)的条件始终为热中性(20 - 22摄氏度,相对湿度25 - 35%);而第一次挑战(Ch1)在热中性条件下进行两次,在温暖潮湿呼吸条件(33 - 35摄氏度,相对湿度90 - 95%)下进行两次。采用双盲设计,用安慰剂或消炎痛进行了3天的预处理。在每次挑战前后多次测量一秒用力呼气量(FEV1)。将安慰剂热中性试验中Ch1后FEV1的下降百分比作为参考。每次测试时的“保护百分比”表示为Ch2后与参考相比EIA的降低程度。温暖潮湿呼吸使Ch1后的EIA降低了75%,同时在热中性条件下提供了类似的保护。消炎痛在Ch1后对EIA没有显著影响,但在温暖潮湿(从67%降至16%)和热中性(从70%降至26%)条件下均降低了“保护百分比”。(摘要截选至250字)